Year |
Citation |
Score |
2017 |
Shao Y, Shaw M, Khrestian M, D'Aleo G, Leverenz JB, Bekris LM. [P2-195]: DNA METHYLATION STATUS OF AN EXTENDED APOE
LOCUS REGION IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 13: P681-P681. DOI: 10.1016/J.Jalz.2017.06.846 |
0.311 |
|
2014 |
Millard SP, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang D, Yu CE, Peskind ER, Bekris LM. Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiology of Aging. 35: 357-64. PMID 24011543 DOI: 10.1016/J.Neurobiolaging.2013.07.027 |
0.349 |
|
2013 |
Yu CE, Cudaback E, Foraker J, Thomson Z, Leong L, Lutz F, Gill JA, Saxton A, Kraemer B, Navas P, Keene CD, Montine T, Bekris LM. Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22: 5036-47. PMID 23892237 DOI: 10.1093/Hmg/Ddt354 |
0.373 |
|
2013 |
Li G, Bekris LM, Leong L, Steinbart EJ, Shofer JB, Crane PK, Larson EB, Peskind ER, Bird TD, Yu CE. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE ε3/ε3. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 554-61. PMID 23183136 DOI: 10.1016/J.Jalz.2012.06.009 |
0.335 |
|
2013 |
Yu C, Bekris L, Thomson Z, Leong L, Lutz F, Cudaback E, Foraker J. O5-01-03: Epigenetic signature of the human APOE gene: Implications in Alzheimer's disease Alzheimer's & Dementia. 9: P828-P829. DOI: 10.1016/J.Jalz.2013.04.471 |
0.303 |
|
2012 |
Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 874-83. PMID 22927204 DOI: 10.1002/Ajmg.B.32094 |
0.349 |
|
2012 |
Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiology of Aging. 33: 2229.e1-2229.e9. PMID 22572541 DOI: 10.1016/J.Neurobiolaging.2012.03.013 |
0.366 |
|
2012 |
Bekris LM, Lutz F, Yu CE. Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. Journal of Human Genetics. 57: 18-25. PMID 22089642 DOI: 10.1038/Jhg.2011.123 |
0.341 |
|
2011 |
Korvatska O, Estes A, Munson J, Dawson G, Bekris LM, Kohen R, Yu CE, Schellenberg GD, Raskind WH. Mutations in the TSGA14 gene in families with autism spectrum disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 303-11. PMID 21438139 DOI: 10.1002/Ajmg.B.31162 |
0.301 |
|
2011 |
Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, et al. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiology of Aging. 32: 556.e13-23. PMID 21196064 DOI: 10.1016/J.Neurobiolaging.2010.10.020 |
0.378 |
|
2011 |
Li GG, Bekris L, Steinbart E, Bird T, Yu C. P1-245: TOMM40 Poly-T Length Variant and Age-At-Onset in Familial AD Caused by PSEN1 and PSEN2 Mutation Alzheimer's & Dementia. 7: S189-S189. DOI: 10.1016/J.Jalz.2011.05.525 |
0.31 |
|
2010 |
Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. Journal of Geriatric Psychiatry and Neurology. 23: 213-27. PMID 21045163 DOI: 10.1177/0891988710383571 |
0.345 |
|
2010 |
Örtqvist E, Brooks-Worrell B, Lynch K, Radtke J, Bekris LM, Kockum I, Agardh CD, Cilio CM, Lethagen AL, Persson B, Lernmark A, Reichow J, Oak S, Palmer JP, Hampe CS. Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity Journal of Clinical Endocrinology and Metabolism. 95. PMID 20685858 DOI: 10.1210/Jc.2010-0785 |
0.356 |
|
2010 |
Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu CE. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 409-17. PMID 19554612 DOI: 10.1002/Ajmg.B.30993 |
0.358 |
|
2010 |
Bekris LM, Galloway N, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, Yu CE. P1-056: Genetic variation within APP processing genes correlates with cerebrospinal fluid APP cleavage product levels in Alzheimer patients and cognitively normal subjects Alzheimer's & Dementia. 6: S189-S190. DOI: 10.1016/J.Jalz.2010.05.604 |
0.317 |
|
2009 |
Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. Plos One. 4: e5424. PMID 19412541 DOI: 10.1371/Journal.Pone.0005424 |
0.331 |
|
2008 |
Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, et al. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. Journal of Alzheimer's Disease : Jad. 13: 255-66. PMID 18430993 DOI: 10.3233/Jad-2008-13303 |
0.367 |
|
2007 |
Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association. 115: 221-8. PMID 17479437 DOI: 10.1055/S-2007-970574 |
0.581 |
|
2007 |
Bekris LM, Jensen RA, Lagerquist E, Hall TR, Agardh CD, Cilio CM, Lethagen AL, Lernmark A, Robertson JA, Hampe CS. GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination. Diabetic Medicine : a Journal of the British Diabetic Association. 24: 521-6. PMID 17367313 DOI: 10.1111/J.1464-5491.2007.02091.X |
0.356 |
|
2007 |
Hoeldtke RD, Hampe CS, Bekris LM, Hobbs G, Bryner KD, Lernmark A. Antibodies to GAD65 and peripheral nerve function in the DCCT. Journal of Neuroimmunology. 185: 182-9. PMID 17328966 DOI: 10.1016/J.Jneuroim.2007.01.009 |
0.33 |
|
2006 |
Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC, Sheridan CM, Glusman G, Hood L, Lernmark A, Janer M. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. American Journal of Human Genetics. 79: 614-27. PMID 16960798 DOI: 10.1086/507876 |
0.39 |
|
2006 |
Zangeneh F, Arora PS, Dyck PJ, Bekris L, Lernmark A, Achenbach SJ, Oberg AL, Rizza RA. Effects of duration of type 2 diabetes mellitus on insulin secretion. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 12: 388-93. PMID 16939949 DOI: 10.4158/Ep.12.4.388 |
0.362 |
|
2006 |
Bekris LM, Viernes HM, Farin FM, Maier LA, Kavanagh TJ, Takaro TK. Chronic beryllium disease and glutathione biosynthesis genes. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 48: 599-606. PMID 16766924 DOI: 10.1097/01.Jom.0000201845.02369.Ba |
0.522 |
|
2006 |
Bekris LM, Kavanagh TJ, Lernmark A. Targeting type 1 diabetes before and at the clinical onset of disease. Endocrine, Metabolic & Immune Disorders Drug Targets. 6: 103-24. PMID 16611168 DOI: 10.2174/187153006776056576 |
0.565 |
|
2005 |
Bekris LM, Shephard C, Peterson M, Hoehna J, Van Yserloo B, Rutledge E, Farin F, Kavanagh TJ, Lernmark A. Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity. 38: 567-75. PMID 16390810 DOI: 10.1080/08916930500407238 |
0.601 |
|
2005 |
Padoa CJ, Crowther NJ, Thomas JW, Hall TR, Bekris LM, Torn C, Landin-Olsson M, Ortqvist E, Palmer JP, Lernmark A, Hampe CS. Epitope analysis of insulin autoantibodies using recombinant Fab. Clinical and Experimental Immunology. 140: 564-71. PMID 15932520 DOI: 10.1111/J.1365-2249.2005.02802.X |
0.324 |
|
2004 |
Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, Obinu DA, Manconi A, Puddu L, Lynch K, Lernmark A. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes. The Journal of Clinical Endocrinology and Metabolism. 89: 5675-82. PMID 15531528 DOI: 10.1210/Jc.2004-0864 |
0.373 |
|
2004 |
Luo D, Gilliam LK, Greenbaum C, Bekris L, Hampe CS, Daniels T, Richter W, Marcovina SM, Rolandsson O, Landin-Olsson M, Kockum I, Lernmark A. Conformation-dependent GAD65 autoantibodies in diabetes. Diabetologia. 47: 1581-91. PMID 15365614 DOI: 10.1007/S00125-004-1495-3 |
0.387 |
|
2003 |
Boutin P, Dina C, Vasseur F, Dubois S, Corset L, Séron K, Bekris L, Cabellon J, Neve B, Vasseur-Delannoy V, Chikri M, Charles MA, Clement K, Lernmark A, Froguel P. GAD2 on chromosome 10p12 is a candidate gene for human obesity Plos Biology. 1. PMID 14691540 DOI: 10.1371/Journal.Pbio.0000068 |
0.337 |
|
2003 |
Niklasson B, Heller KE, Schønecker B, Bildsøe M, Daniels T, Hampe CS, Widlund P, Simonson WT, Schaefer JB, Rutledge E, Bekris L, Lindberg AM, Johansson S, Ortqvist E, Persson B, et al. Development of type 1 diabetes in wild bank voles associated with islet autoantibodies and the novel ljungan virus. International Journal of Experimental Diabesity Research. 4: 35-44. PMID 12745669 DOI: 10.1080/15438600303733 |
0.382 |
|
2002 |
Chessler SD, Hampe CS, Ortqvist E, Simonson WT, Bekris L. Immune reactivity to GAD25 in type 1 diabetes mellitus. Autoimmunity. 35: 335-41. PMID 12515288 DOI: 10.1080/0891693021000005402 |
0.416 |
|
2002 |
Mohatt J, Gilliam LK, Bekris L, Ebbesson S, Lernmark A. Type 1 diabetes-related autoantibodies are rare in Alaska native populations International Journal of Circumpolar Health. 61: 21-31. PMID 12002943 DOI: 10.3402/Ijch.V61I1.17402 |
0.375 |
|
2002 |
Maioli M, Tonolo G, Bekris L, Cirillo R, Schranz D, Cossu E, Ciccarese M, Lernmark A. GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families. Diabetes Research and Clinical Practice. 56: 41-7. PMID 11879720 DOI: 10.1016/S0168-8227(01)00348-5 |
0.377 |
|
2002 |
Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset. Journal of Autoimmunity. 18: 49-53. PMID 11869046 DOI: 10.1006/Jaut.2001.0564 |
0.402 |
|
2000 |
Hampe CS, Hammerle LP, Bekris L, Örtqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Torn C, Persson B, Lernmark A. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes Journal of Clinical Endocrinology and Metabolism. 85: 4671-4679. PMID 11134126 DOI: 10.1210/Jcem.85.12.7070 |
0.387 |
|
2000 |
Novak EJ, Ortqvist E, Nord E, Edwall L, Hampe CS, Bekris L, Persson BE, Lernmark A. Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function. Diabetes Care. 23: 1019-21. PMID 10895858 DOI: 10.2337/Diacare.23.7.1019 |
0.354 |
|
1998 |
Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Grönlund H, Toivola B, Lernmark A. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). Journal of Immunological Methods. 213: 87-97. PMID 9671127 DOI: 10.1016/S0022-1759(98)00025-8 |
0.381 |
|
Show low-probability matches. |